Dong-A Socio Holdings Co., Ltd. (KRX:000640)
113,900
-1,100 (-0.96%)
At close: Jun 5, 2025, 3:30 PM KST
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 328.40B KRW in the quarter ending March 31, 2025, with 7.70% growth. This brings the company's revenue in the last twelve months to 1.36T, up 14.84% year-over-year. In the year 2024, Dong-A Socio Holdings had annual revenue of 1.33T with 17.78% growth.
Revenue (ttm)
1,356.71B
Revenue Growth
+14.84%
P/S Ratio
0.54
Revenue / Employee
245.34M
Employees
5,530
Market Cap
733.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,333.23B | 201.23B | 17.78% |
Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |